General contact

Novartis Pharmaceuticals UK Limited
UK Head Office
Frimley Business Park Frimley
Camberley Surrey GU16 7SR

+44 1276 692255
+44 1276 692508
Monday - Friday,
8:30 - 17:30

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Novartis UK Press Office
Press Office enquiries only

+44 1276 698691

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine. More information

Product Information

For enquiries contact

+44 1276 698 370

pane 4 content

Alcon DAILIES TOTAL1

News

Novartis Annual Report 2014

27 January 2014 Novartis has announced the full year results for 2014.

Announcement of possible sale of Novartis site in Horsham to the University of Brighton

26 January 2015 We are delighted to be able to confirm that we are entering into exclusive negotiations with the University of Brighton for the sale of our former Horsham site at Wimblehurst Road.

Novartis completes divestment of Animal Health business to Eli Lilly for USD 5.4 billion

1 January 2015 Novartis has completed effective January 1, 2015 the divestment of its Animal Health Division to Eli Lilly and Company (Lilly).

New data from PARADIGM-HF show Novartis’ heart failure drug LCZ696 keeps patients alive longer and in better health than current gold standard ACE inhibitor (enalapril)

21 November 2014 New analyses was presented at the American Heart Association (AHA) Scientific Sessions show.

Top Links